Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2012
04/19/2012US20120095193 Polypeptides and method of treatment
04/19/2012US20120095192 Use of trifunctional bispecific antibodies for the treatment of tumors associated with the cd133+/epcam+ cancer stem cells
04/19/2012US20120095191 Lh-type bispecific antibody
04/19/2012US20120095185 Process for chelating copper ions using cb-te2a bifunctional chelate
04/19/2012US20120095165 Affinity material
04/19/2012US20120094874 Stabilized immunoglobulin constant domains
04/19/2012US20120094860 Compositions, Antibodies, Asthma Diagnosis Methods, and Methods for Preparing Antibodies
04/19/2012US20120094377 Modified Fluorescent Proteins and Methods for Using Same
04/19/2012US20120094316 Drug Detection
04/19/2012US20120094299 Nucleotide repeat expansion-associated polypeptides and uses thereof
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120094272 Signal enhancement system with multiple labeled-moieties
04/19/2012US20120093868 Haemophilus influenzae type b
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093858 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
04/19/2012US20120093851 Chlamydia antigens
04/19/2012US20120093845 Neil3 peptides and vaccines including the same
04/19/2012US20120093842 Chimeric receptor genes and cells transformed therewith
04/19/2012US20120093839 Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
04/19/2012US20120093838 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
04/19/2012US20120093837 Compositions and methods for detecting egfr in cancer
04/19/2012US20120093835 Anti-inflammatory antibodies and uses therefor
04/19/2012US20120093833 Human Oncostatin M Antibodies and Methods of Use
04/19/2012US20120093830 Single domain antibodies that bind il-13
04/19/2012US20120093826 Fully human antibodies specific to cadm1
04/19/2012US20120093823 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
04/19/2012US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
04/19/2012US20120093818 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
04/19/2012US20120093816 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus
04/19/2012US20120093814 Fusion Proteins Comprising Canine FC Portions
04/19/2012US20120093813 Anti notch-1 antibodies
04/19/2012US20120093811 Anti-vegf-d antibodies
04/19/2012US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
04/19/2012US20120093808 Humanized pcrv antibody having anti-pseudomonal activity
04/19/2012US20120093805 Anti-cd27 humanized monoclonal antibody
04/19/2012US20120093788 Protease for wound conditioning and skin care
04/19/2012US20120093769 Stem Cell Targeting with Dock-and-Lock (DNL) Complexes
04/19/2012US20120093734 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
04/19/2012US20120093733 Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use
04/19/2012US20120093731 Gas-filled microvesicles with targeting ligand or therapeutic agent
04/19/2012US20120093730 Molecular death tags and methods of their use
04/19/2012US20120093723 Nanocarrier compositions and methods
04/19/2012US20120093719 Antibodies against prostate specific membrane antigen
04/19/2012CA2851102A1 Biomarker and method for detecting a chronic inflammatory-associated disease
04/19/2012CA2817973A1 Antibodies that bind amyloid oligomers
04/19/2012CA2814652A1 Human oncostatin m antibodies and methods of use
04/19/2012CA2814431A1 Therapies for improving pulmonary function
04/19/2012CA2813493A1 Human anti-tau antibodies
04/18/2012EP2442109A1 Cancer biomarkers and methods of use thereof
04/18/2012EP2442108A1 Cancer biomarkers and methods of use thereof
04/18/2012EP2441838A2 Fusion proteins that contain natural junctions
04/18/2012EP2441832A1 Novel protein and gene that codes therefor
04/18/2012EP2441777A2 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
04/18/2012EP2441472A1 Tumor therapy with an anti-VEGF antibody
04/18/2012EP2441466A1 Method for modulating appetite
04/18/2012EP2440580A1 ANTI-EpCAM ANTIBODIES
04/18/2012EP2440579A2 Antibodies
04/18/2012EP2440578A2 Use of an anti-tau ps422 antibody for the treatment of brain diseases
04/18/2012EP2200647B1 Antibodies specific for human hepcidin
04/18/2012EP2074143B1 Altered antibodies
04/18/2012EP2027154B1 Immunoglobulin constant region domains with enhanced stability
04/18/2012EP1718677B1 Monovalent antibody fragments useful as therapeutics
04/18/2012EP1709083B1 Adenocarcinoma specific antibody sam-6, and uses thereof
04/18/2012EP1708745B1 Antibodies for oncogenic strains of hpv and methods of their use
04/18/2012EP1658500B1 Methods for obtaining antibodies
04/18/2012EP1534750B1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
04/18/2012EP1183368B1 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung
04/18/2012EP1005488B9 Receptor that binds trail
04/18/2012CN1418225B Monoclonal antibodies to the human ldl receptor, their production and use
04/18/2012CN102421802A 人源化的axl抗体 Humanized antibodies axl
04/18/2012CN102421801A 抗-bcma抗体 Anti--bcma antibody
04/18/2012CN102421800A 结合cd19的人源化抗体及其用途 Binding cd19 humanized antibodies and uses thereof
04/18/2012CN102421799A Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
04/18/2012CN102421798A Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
04/18/2012CN102421795A 针对肌钙蛋白i的抗体及其使用方法 Antibodies against troponin i and method of use
04/18/2012CN102421482A Antibodies specifically directed to the soluble form of ctla-4
04/18/2012CN102417895A Monoclonal antibody for beta-conglycinin beta-subunit and application of monoclonal antibody
04/18/2012CN101948807B 一种抗重金属汞离子抗体及其应用 An anti-antibody heavy metal mercury ions and its application
04/18/2012CN101892248B 禽流感h5 ha抗原的单克隆抗体 Avian influenza antigen monoclonal antibody h5 ha
04/18/2012CN101173279B Scirr69基因、调节bdnf转录及在生物医学研究、生物治疗药物研发中的应用 Scirr69 genes regulating bdnf transcription and in biomedical research, drug discovery and development in the application of biological treatment
04/17/2012US8158762 Anti-factor B antibodies and their uses
04/17/2012US8158761 Wnt proteins and detection and treatment of cancer
04/17/2012US8158760 Glycoengineered, recombinant antibody
04/17/2012US8158573 Therapeutic and diagnostic conjugates for use with multispecific antibodies
04/17/2012US8158386 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
04/17/2012US8158385 Cell death-inducing agent
04/17/2012US8158365 Anti-2-O-desulfated acharan sulfate antibody and its application
04/17/2012US8158130 Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
04/17/2012US8158127 Compounds for neutralizing the effects of secreted PLA2 IIA
04/17/2012US8158126 Stem cell fusion model of carcinogenesis
04/17/2012US8158124 Compositions and methods for binding lysophosphatidic acid
04/17/2012US8158123 Suppressing bone resorption; inhibiting expression of osteoclast associated gene selected from OC 1-285, sequences 4, 34, 38 and/or 43
04/17/2012CA2510664C Anthracycline-antibody conjugates
04/17/2012CA2506672C Il-23 for treating cutaneous wounds
04/17/2012CA2505995C Cobalamin assay
04/17/2012CA2499008C Compositions and methods comprising a ligand of chemerinr
04/17/2012CA2497982C Peptides and related molecules that modulate nerve growth factor activity
04/17/2012CA2492671C Humanized antibody and process for preparing same
04/17/2012CA2431600C Molecules with extended half-lives, compositions and uses thereof
04/17/2012CA2377607C Neurotrophic factor receptor
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 1494